Circadian clock components RORα and Bmal1 mediate the anti-proliferative effect of MLN4924 in osteosarcoma cells. - Test2 - elhamkhani - TriplyDB

Circadian clock components RORα and Bmal1 mediate the anti-proliferative effect of MLN4924 in osteosarcoma cells.

Circadian clock components RORα and Bmal1 mediate the anti-proliferative effect of MLN4924 in osteosarcoma cells.

http://www.wikidata.org/entity/Q37662370

about

The MiR-135b-BMAL1-YY1 loop disturbs pancreatic clockwork to promote tumourigenesis and chemoresistance.Cryptochrome 2 (CRY2) Suppresses Proliferation and Migration and Regulates Clock Gene Network in Osteosarcoma Cells.

P2860

Q49358224-19DA11DA-5F6C-4786-8FFC-DDD6F155CB3E Q54976797-3B1573B3-4598-472C-89BD-474302ACF8FB

P2860

Circadian clock components RORα and Bmal1 mediate the anti-proliferative effect of MLN4924 in osteosarcoma cells.

http://www.wikidata.org/entity/Q37662370

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Circadian clock components ROR ...... MLN4924 in osteosarcoma cells.

@en

Circadian clock components ROR ...... MLN4924 in osteosarcoma cells.

@nl

type

label

Circadian clock components ROR ...... MLN4924 in osteosarcoma cells.

@en

Circadian clock components ROR ...... MLN4924 in osteosarcoma cells.

@nl

prefLabel

Circadian clock components ROR ...... MLN4924 in osteosarcoma cells.

@en

Circadian clock components ROR ...... MLN4924 in osteosarcoma cells.

@nl

P1433

Q37662370-643E2967-D2D7-4738-8515-B3029B09F012

P1476

Q37662370-635176CD-267A-44CF-9A5D-7A9E61B2E2B4

P2093

Q37662370-46FF694A-AB2A-4B21-8304-3E23EF2EA317

Q37662370-7C0F6B4C-72F3-48C2-92EB-82B338A32059

Q37662370-80F18A0E-ED51-4560-AE21-F60559A63145

Q37662370-A3CF4F0F-001A-4320-9BFE-8BD199E4C7D4

Q37662370-A7D7871F-7EC1-4F7C-82C4-7A3DA0E74399

Q37662370-BD6C5941-6FFA-4C6C-A5C8-156BA2818ECB

Q37662370-F2745560-C8E2-4C90-8749-20D765F5117D

Q37662370-FC1C8389-2BE0-458E-B489-C018098B3A05

P2860

Q37662370-193857B2-4B25-4D6D-A6D2-BBEA53C49463

Q37662370-1E83F34D-9A59-4159-9ACD-39DABFC04165

Q37662370-210B4100-7726-4281-AFFE-07820CE219B5

Q37662370-40C4B99C-B0C5-4214-8FF1-3D8084F63EC9

Q37662370-4E057DD1-1BD3-42C0-8B79-2F9DAD314205

Q37662370-5383C569-273D-4709-9D21-73A6B010D5C8

Q37662370-5C220298-11E9-4B20-9951-E70424CC64C7

Q37662370-65853723-73E8-449A-AEA0-8524D039D38F

Q37662370-6FC13DB9-A5F0-418C-AD5F-C3675634AE77

Q37662370-7B3CC079-1195-4095-AB64-B3422A8DD1E4

P304

Q37662370-D4843391-A1D1-42E1-B0E4-1E5B47B82640

P31

Q37662370-10ECDD66-7A77-4ACE-8737-9A618FDE8756

P356

Q37662370-7262C2D7-6D8B-4F43-9524-E3A262A37265

P407

Q37662370-55FA2C73-E4AD-4E55-B2BC-C43A9E7E63EE

P433

Q37662370-50E4FE58-5F77-4D04-940A-97B8BA6221DF

P478

Q37662370-C9B10E43-5E13-4D67-9A42-746A6A923514

P577

Q37662370-A87F83ED-8A05-4AC0-8653-5F3E00699D5B

P698

Q37662370-E1723451-D4DD-4CCF-A75E-35428CD9AE72

P921

Q37662370-4DFFB0AA-2457-4E0B-B0CB-06E27AFB19EF

P932

Q37662370-9A42F834-D4E4-45D7-A6EF-C028DB7FF412

P356

ONCOTARGET.11807

P1433

P1476

Circadian clock components ROR ...... MLN4924 in osteosarcoma cells.

@en

P2093

Fang Jiang

http://www.w3.org/2001/XMLSchema#string

Huadie Liu

http://www.w3.org/2001/XMLSchema#string

Jia-Da Li

http://www.w3.org/2001/XMLSchema#string

Jiaming Zhang

http://www.w3.org/2001/XMLSchema#string

Shuju Zhang

http://www.w3.org/2001/XMLSchema#string

Wei Mao

http://www.w3.org/2001/XMLSchema#string

Zanxian Xia

http://www.w3.org/2001/XMLSchema#string

Zhiyuan Deng

http://www.w3.org/2001/XMLSchema#string

P2860

Osteosarcoma: Current Treatment and a Collaborative Pathway to Success

Circadian clock protein BMAL1 regulates cellular senescence in vivo

Ubiquitin E3 ligase CRL4(CDT2/DCAF2) as a potential chemotherapeutic target for ovarian surface epithelial cancer

An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer

NEDD8-targeting drug MLN4924 elicits DNA rereplication by stabilizing Cdt1 in S phase, triggering checkpoint activation, apoptosis, and senescence in cancer cells

Cul4B regulates neural progenitor cell growth.

Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma.

Disrupting circadian homeostasis of sympathetic signaling promotes tumor development in mice.

MLN4924, an NAE inhibitor, suppresses AKT and mTOR signaling via upregulation of REDD1 in human myeloma cells.

RORalpha attenuates Wnt/beta-catenin signaling by PKCalpha-dependent phosphorylation in colon cancer.

P304

66087-66099

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.11807

http://www.w3.org/2001/XMLSchema#string

P407

P433

40

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27602774

http://www.w3.org/2001/XMLSchema#string

P921

circadian rhythm

P932

5323217

http://www.w3.org/2001/XMLSchema#string